NanoEcho
0,04 SEK
−0,51 %
NANECH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
NanoEcho operates in the healthcare sector, with a primary focus on rectal cancer diagnostics. The company is currently in the clinical stage, developing a new diagnostic method to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide an accurate diagnosis and personalized treatment. NanoEcho was founded in 2013 and is headquartered in Lund.
Lue lisääLiikevaihto ja EBIT-%
Liikevaihto t.
EBIT-% (oik.)
EPS ja Osinko
EPS (oik.)
Osinko %
Pörssikalenteri
Yhtiökokous '26
Osavuosikatsaus Q2'26
Osavuosikatsaus Q3'26